Hunter Perkins Capital Management, LLC Merck & Co., Inc. Transaction History

Hunter Perkins Capital Management, LLC

$451 Million
Q3 2025

A detailed history of Hunter Perkins Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hunter Perkins Capital Management, LLC holds 112,811 shares of MRK stock, worth $10.5 Million. This represents 2.12% of its overall portfolio holdings.

Number of Shares

112,811

Previous 113,392 0.51%

Holding current value

$10.5 Million

Previous $9.07 Million 5.41%

% of portfolio

2.12%

Previous 2.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$77.6 - $87.37 $45,085 - $50,761	-581 Reduced 0.51%	112,811 $9.56 Million
Q2 2025 Jul 22, 2025	BUY	$73.47 - $87.12 $72,588 - $86,074	988 Added 0.88%	113,392 $9.07 Million
Q1 2025 Apr 24, 2025	SELL	$83.01 - $101.02 $1.99 Million - $2.43 Million	-24,018 Reduced 17.61%	112,404 $10.2 Million
Q4 2024 Jan 22, 2025	BUY	$96.31 - $114.76 $3.5 Million - $4.16 Million	36,292 Added 36.24%	136,422 $13.7 Million
Q3 2024 Oct 16, 2024	BUY	$111.15 - $128.97 $905,094 - $1.05 Million	8,143 Added 8.85%	100,130 $11.4 Million

Q2 2024 Jul 17, 2024	SELL	$123.8 - $132.96 $165,892 - $178,166	-1,340 Reduced 1.44%	91,987 $11.4 Million
Q1 2024 Apr 23, 2024	SELL	$113.24 - $131.95 $723,603 - $843,160	-6,390 Reduced 6.41%	93,327 $12.4 Million
Q4 2023 Jan 18, 2024	BUY	$100.18 - $109.02 $8.64 Million - $9.4 Million	86,247 Added 640.29%	99,717 $10.9 Million
Q3 2023 Oct 19, 2023	SELL	$102.95 - $114.33 $1.57 Million - $1.74 Million	-15,225 Reduced 53.06%	13,470 $1.39 Million
Q2 2023 Jul 18, 2023	BUY	$108.61 - $118.38 $1.33 Million - $1.45 Million	12,270 Added 74.7%	28,695 $1.42 Million
Q1 2023 Apr 14, 2023	SELL	$102.94 - $114.86 $30,882 - $34,458	-300 Reduced 1.79%	16,425 $1.75 Million
Q4 2022 Jan 17, 2023	SELL	$87.44 - $112.11 $306,040 - $392,385	-3,500 Reduced 17.31%	16,725 $1.86 Million
Q3 2022 Oct 13, 2022	SELL	$84.53 - $94.96 $393,064 - $441,564	-4,650 Reduced 18.69%	20,225 $1.75 Million
Q2 2022 Jul 20, 2022	SELL	$83.49 - $94.64 $17.4 Million - $19.7 Million	-208,506 Reduced 89.34%	24,875 $2.27 Million
Q1 2022 Apr 27, 2022	SELL	$73.51 - $82.4 $162,751 - $182,433	-2,214 Reduced 0.94%	233,381 $19.1 Million
Q4 2021 Jan 27, 2022	SELL	$72.28 - $90.54 $2.84 Million - $3.56 Million	-39,340 Reduced 14.31%	235,595 $18.1 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $1 Million - $1.1 Million	13,985 Added 5.36%	274,935 $20.7 Million
Q2 2021 Jul 30, 2021	BUY	$70.31 - $77.77 $3.26 Million - $3.61 Million	46,400 Added 21.63%	260,950 $20.3 Million
Q1 2021 Apr 28, 2021	BUY	$68.86 - $81.11 $12.1 Million - $14.2 Million	175,442 Added 448.61%	214,550 $16.5 Million
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $2.81 Million - $3.11 Million	39,108 New	39,108 $3.2 Million

Others Institutions Holding MRK

# of Institutions

3,878

Shares Held

1.9B

Call Options Held

30.1M

Put Options Held

27.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Perkins Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Perkins Capital Management, LLC with notifications on news.

Account

Hunter Perkins Capital Management, LLC Merck & Co., Inc. Transaction History